Literature DB >> 9613757

Proton MR spectroscopic findings in paroxysmal kinesigenic dyskinesia.

M O Kim1, J H Im, C G Choi, M C Lee.   

Abstract

Although paroxysmal kinesigenic dyskinesia (PKD) has characteristic clinical features, the pathophysiology of PKD has remained unknown. The purpose of this study was to investigate the pathophysiology of idiopathic PKD by performing proton magnetic resonance spectroscopy (1H-MRS) in five patients with idiopathic PKD. Three patients were familial and two sporadic. Single-voxel 1H-MRS was performed on a GE 1.5-T SIGNA MR system. Localized 1H-MR spectra were obtained from the basal ganglia (n = 5), thalamus (n = 3), and supplementary motor area (SMA; n = 4) using STEAM sequence (stimulated echo acquisition mode; TR = 3.0 sec, TE = 30 msec, 64 AVG, volume = 8 mL) or PRESS (point resolved spectroscopy; TR = 3.0 sec, TE = 135 msec, volume = 4 mL). Peak ratios of Cho/Cr (Cho: choline, Cr: creatine) and mI/Cr (mI: myoinositol) were decreased significantly in the unilateral basal ganglia of two patients. In one, decreased peak ratio of mI/Cr in the unilateral basal ganglia was the only abnormality. In the remaining two, there was no significant abnormality. 1H-MR spectra obtained from the thalamus and SMA were all within normal limits. In conclusion, these results suggest that underlying pathophysiological mechanism of PKD may be at least partially associated with the dysfunction of cholinergic system in the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613757     DOI: 10.1002/mds.870130334

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  2 in total

1.  Altered intrinsic brain activity in patients with paroxysmal kinesigenic dyskinesia by PRRT2 mutation: altered brain activity by PRRT2 mutation.

Authors:  ChunYan Luo; Yongping Chen; Wei Song; Qin Chen; QiYong Gong; Hui-Fang Shang
Journal:  Neurol Sci       Date:  2013-03-27       Impact factor: 3.307

Review 2.  Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China.

Authors:  Li Cao; Xiaojun Huang; Ning Wang; Zhiying Wu; Cheng Zhang; Weihong Gu; Shuyan Cong; Jianhua Ma; Ling Wei; Yanchun Deng; Qi Fang; Qi Niu; Jin Wang; Zhaoxia Wang; You Yin; Jinyong Tian; Shufen Tian; Hongyan Bi; Hong Jiang; Xiaorong Liu; Yang Lü; Meizhen Sun; Jianjun Wu; Erhe Xu; Tao Chen; Tao Chen; Xu Chen; Wei Li; Shujian Li; Qinghua Li; Xiaonan Song; Ying Tang; Ping Yang; Yun Yang; Min Zhang; Xiong Zhang; Yuhu Zhang; Ruxu Zhang; Yi Ouyang; Jintai Yu; Quanzhong Hu; Qing Ke; Yuanrong Yao; Zhe Zhao; Xiuhe Zhao; Guohua Zhao; Furu Liang; Nan Cheng; Jianhong Han; Rong Peng; Shengdi Chen; Beisha Tang
Journal:  Transl Neurodegener       Date:  2021-02-16       Impact factor: 8.014

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.